Upstream Bio Inc (UPB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 683 | 937 | 566 | 613 | 607 |
| Gross Profit | 683 | 937 | 566 | 613 | 607 |
| Operating Expenses | 38,517 | 45,284 | 32,579 | 26,931 | 19,500 |
| Operating Income | -37,834 | -44,347 | -32,013 | -26,318 | -18,893 |
| Other Income | 4,086 | 4,381 | 4,743 | 5,076 | 2,901 |
| Pre-tax Income | -33,748 | -39,966 | -27,270 | -21,242 | -15,992 |
| Net Income Continuous | -33,748 | -39,966 | -27,270 | -21,242 | -15,992 |
| Net Income | $-33,748 | $-39,966 | $-27,270 | $-21,242 | $-15,992 |
| EPS Basic Total Ops | -0.63 | -0.74 | -0.51 | 12.56 | -6.96 |
| EPS Basic Continuous Ops | -0.63 | -0.74 | -0.51 | 9.21 | -5.29 |
| EPS Diluted Total Ops | -0.63 | -0.74 | -0.51 | 12.56 | -6.96 |
| EPS Diluted Continuous Ops | -0.63 | -0.74 | -0.51 | 9.21 | -5.29 |
| EPS Diluted Before Non-Recurring Items | -0.63 | -0.74 | -0.51 | N/A | -6.96 |
| EBITDA(a) | $-37,942 | $-45,290 | $-33,705 | $-25,587 | $-19,451 |